Dr. Michele Columbo, MD

Dr. Columbo practices at Columbo Asthma Allergy & Immunology in Bryn Mawr, Pennsylvania.

Dr. Columbo's NPI, 1538151220, was assigned on August 18, 2005. Dr. Columbo graduated from University of Naples Faculty of Medicine in 1983. Dr. Columbo holds Pennsylvania license MD071522L.

Dr. Columbo's primary practice is Columbo Asthma Allergy & Immunology, at 830 Old Lancaster Rd, Bryn Mawr, PA 19010 in Delaware County. The practice phone is (610) 527-2000.

Dr. Columbo's primary practice is Columbo Asthma Allergy & Immunology in Bryn Mawr, Pennsylvania. Dr. Columbo is also affiliated with Bryn Mawr Hospital. Dmand AI also links Dr. Columbo to 3 more hospitals and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Columbo practices, 5 sites in all. Vendor and product names are available with a free account.

General practice is Dr. Columbo's primary specialty in the NPI Registry, under taxonomy code 208D00000X. Dr. Columbo is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Columbo's licenses on file in 3 states: Pennsylvania, Virginia and Maryland.

Dmand AI lists acute sinusitis, asthma, chronic nasal allergies, chronic sinusitis, hives, immune deficiency disease and upper respiratory infection (URI) among the conditions Dr. Columbo treats.

CMS data shows 13,682 Medicare services from Dr. Columbo across 17 procedure codes in 2024, for 366 Medicare patients. Medicare paid $340,466 for them. Every service was in an office.

CMS counts 366 Medicare patients who saw Dr. Columbo in 2024. The largest group is 65 to 74, with 163 patients. 75% of them have high cholesterol, and 68% have high blood pressure. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Columbo's median patient age at 58, with 61% women.

In 2024, Dr. Columbo wrote 1,192 Medicare Part D claims for 243 patients. 61% of them were for generic drugs. CMS names the drug for 1,057 of them, across 25 drugs with 11 or more claims each, at $1,613,734 in total drug cost. In 2023, CMS named 1,066 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Columbo for performance year 2024, reported as part of a group. Dr. Columbo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Columbo as offering telehealth.

Dmand AI links 30 papers to Dr. Columbo, published from 2009 to 2021. 2013 was the busiest year, with 2. The most frequent topics are Basophils, Histamine Release and Immunoglobulin E. Dr. Columbo has published most often in Allergy Asthma Clin Immunol. Dr. Columbo's most frequent co-authors are Albert Schumm Rohr, MD, Michael D. Ezekowitz, MD and Stephen Joseph Galli, MD.

Dmand AI links Dr. Columbo to 7 clinical trials, 3 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Asthma, Respiratory Hypersensitivity and Rhinitis. Rohr and Columbo Asthma, Allergy and Immunology Specialists, P.C. sponsors the most, 6.

CMS Open Payments shows 1,340 general payments to Dr. Columbo from 48 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 71% of the total. Shire North American Group Inc paid the most, $216,222.

Dmand AI lists 2 awards for Dr. Columbo, most recently Regional Top Doctor in 2023.

Dr. Columbo graduated from University of Naples Faculty of Medicine in 1983. Dr. Columbo is a member of AAAAI and ACAAI.

Dr. Columbo is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and HCSC. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.